Literature DB >> 18428630

Intravenous self-administration techniques in monkeys.

Donna M Platt1, Galen Carey, Roger D Spealman.   

Abstract

Drug self-administration is a procedure in which a subject performs a response, called an operant, that results in the delivery of a drug injection. This procedure is viewed as a relevant model for the study of human drug-taking behavior. Drug self-administration in primates has several characteristics that resemble drug-taking behavior in humans, and drugs that are commonly abused by humans also typically maintain self-administration behavior in monkeys. Drug self-administration procedures allow for the study of a variety of drug properties. For instance, they are used to investigate the abuse potential of new compounds and to study the effects of candidate medications for the treatment of drug addiction. These procedures also can be used to study the process of drug reinforcement. This unit describes intravenous drug self-administration in large primates, such as rhesus macaques, and smaller primates, such as squirrel monkeys.

Entities:  

Mesh:

Year:  2005        PMID: 18428630     DOI: 10.1002/0471142301.ns0921s32

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  7 in total

1.  Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.

Authors:  C Austin Zamarripa; Jennifer E Naylor; Sally L Huskinson; E Andrew Townsend; Thomas E Prisinzano; Kevin B Freeman
Journal:  Psychopharmacology (Berl)       Date:  2020-01-31       Impact factor: 4.530

2.  Influence of experimental history on nicotine self-administration in squirrel monkeys.

Authors:  Rajeev I Desai; Katherine A Sullivan; Stephen J Kohut; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2016-04-04       Impact factor: 4.530

3.  Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys.

Authors:  Cindy Achat-Mendes; Peter Grundt; Jianjing Cao; Donna M Platt; Amy Hauck Newman; Roger D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2010-05-21       Impact factor: 4.030

4.  The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys.

Authors:  Cindy Achat-Mendes; Donna M Platt; Amy H Newman; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2009-06-10       Impact factor: 4.530

5.  D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning.

Authors:  Bríd A Nic Dhonnchadha; Jonathan J Szalay; Cindy Achat-Mendes; Donna M Platt; Michael W Otto; Roger D Spealman; Kathleen M Kantak
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

6.  8-Substituted Triazolobenzodiazepines: In Vitro and In Vivo Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABAA Receptor.

Authors:  Lalit K Golani; Donna M Platt; Daniela Rüedi-Bettschen; Chitra Edwanker; Shenming Huang; Michael M Poe; Roman Furtmüller; Werner Sieghart; James M Cook; James K Rowlett
Journal:  Front Pharmacol       Date:  2021-04-20       Impact factor: 5.810

Review 7.  From concepts to treatment: a dialog between a preclinical researcher and a clinician in addiction medicine.

Authors:  Youna Vandaele; Jean-Bernard Daeppen
Journal:  Transl Psychiatry       Date:  2022-09-21       Impact factor: 7.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.